The Doxorubicin Hydrochloride for in, cataloged under National Stock Number 6505-01-273-4239, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Erbamont Inc Adria Laboratories Div. Government technical data includes 8 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-273-4239 |
| Primary Part Number | NDC00013-1096-94 |
| Item Name | Doxorubicin Hydrochloride for in |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Erbamont Inc Adria Laboratories Div |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 20.000 MILLIGRAMS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Type | VIAL |
| Physical Form | FREEZE-DRIED POWDER |
| Active Medicament Medicinal Strength | 20.000 MILLIGRAMS DOXORUBICIN HYDROCHLORIDE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 5 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00013-1096-94 PRIMARY | Erbamont Inc Adria Laboratories Div (USA) |
| Reference | Meaning |
|---|---|
| ADRIAMYCIN | 5/1 Secondary reference Erbamont Inc Adria Laboratories Div |
NSN 6505-01-273-4239 is a Doxorubicin Hydrochloride for in, manufactured by Erbamont Inc Adria Laboratories Div, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-273-4239 has 1 manufacturer part number on file: NDC00013-1096-94 (Erbamont Inc Adria Laboratories Div).
Key specifications for NDC00013-1096-94: Administration: INTRAVENOUS; Primary Container Content Quantity: 20.000 MILLIGRAMS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: STERILE. 8 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.